Back to Search Start Over

Oral Presentations—Abstracts

Authors :
M. Bartsch
D. K. F. Meijer
G. L. Scherphof
J. A. A. M. Kamps
S. Erdoğan
A. Y. Özer
B. Caner
H. Bilgili
L. M. Ickenstein
K. Edwards
G. Karlsson
L. D. Mayer
Crispin G. S. Eley
Ning Hu
Gerard M. Jensen
K. Kawahara
A. Sekiguchi
E. Kiyoki
K. Morimoto
O. C. Boerman
M. Miyajima
J. Kimura
G. A. Koning
H. W. M. Morselt
Josbert M. Metselaar
Marca H. M. Wauben
Otto C. Boerman
Peter L. van Lent
Gert Storm
F. Pastorino
C. Brignole
D. Marimpietri
E. H. Moase
T. M. Allen
M. Ponzoni
K. Romøren
B. J. Thu
Ø Evensen
S. Rossi
S. Ristori
G. Martini
R. M. Schiffelers
G. Molema
T. L. M. ten Hagen
A. P. C. A. Janssen
R. G. Ebben
A. J. Schraa
R. J. Kok
G. Koning
G. Storm
S. I. Simões
C. M. Marques
M. E. Cruz
G. Cevc
M. B. Martins
D. Summers
D. Ruff
R. W. Smalling
D. Cardoza
D. Dottavio
D. Lasic
J. Szebeni
L. Baranyi
S. Savay
J. Milosevits
R. Bunger
P. Laverman
J. M. Metselaar
A. Chanan-Khan
L. Liebes
F. M. Muggia
R. Cohen
Y. Barenholz
C. R. Alving
S. Hoving
A. L. B. Seynhaeve
S. T. van Tiel
A. M. M. Eggermont
K. Tokutomi
Y. Sadzuka
A. Igarashi
H. Konno
T. Sonobe
Source :
Journal of Liposome Research. 13:37-50
Publication Year :
2003
Publisher :
Informa UK Limited, 2003.

Abstract

Targeted Delivery of Antisense Oligodeoxynucleotides In Vivo by Means of Coated Cationic LipoplexesEarlier we reported on the massive uptake of liposomes surface-modified with negatively charged aconitylated albumin (Aco-HSA) by liver endothelial cells (EC) in vivo. In the present work we apply this principle for in vivo delivery of antisense oligodeoxynucleotides (ODN) to these cells by means of coated cationic lipoplexes (CCL) (). CCL were prepared by complexing ODN with the cationic lipid DOTAP and subsequent coating of the complex by neutral lipids including a lipid-anchored poly(ethylene glycol). Aco-HSA was covalently coupled.The Aco-HSA-CCLs were 160 nm in size, contained 1.03 ± 0.35 nmol ODN and 54 ± 18 µg Aco-HSA per µ mol total lipid. The Aco-HSA-CCLs were rapidly eliminated from plasma, 60% of the injected dose being recovered in the liver after 30 m. Within the liver, the EC accounted for two thirds of total liver uptake. Non-targeted CCLs were eliminated very slowly: after 30 m >90% of the pa...

Details

ISSN :
15322394 and 08982104
Volume :
13
Database :
OpenAIRE
Journal :
Journal of Liposome Research
Accession number :
edsair.doi...........ec18819ffd04603267c180be390a826a
Full Text :
https://doi.org/10.1081/lpr-120017489